These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 300751)

  • 1. Purification and properties of human lymphocyte activating factor (LAF).
    Blyden G; Handschumacher RE
    J Immunol; 1977 May; 118(5):1631-8. PubMed ID: 300751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.
    Mizel SB; Oppenheim JJ; Rosentreich DL
    J Immunol; 1978 May; 120(5):1504-8. PubMed ID: 307016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons.
    Amento EP; Kurnick JT; Krane SM
    J Immunol; 1985 Jan; 134(1):350-7. PubMed ID: 2578047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of DNA synthesis and cAMP content of mouse thymocytes by mediator(s) derived from adherent cells.
    Oppenheim JJ; Shneyour A; Kook AI
    J Immunol; 1976 May; 116(5):1466-72. PubMed ID: 178798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniques.
    Lachman LB; Hacker MP; Handschumacher RE
    J Immunol; 1977 Dec; 119(6):2019-23. PubMed ID: 915290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
    Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
    Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characterization of lymphocyte-activating factor (LAF).
    Mizel SB
    J Immunol; 1979 Jun; 122(6):2167-72. PubMed ID: 312860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lung macrophages enhance and inhibit lymphocyte proliferation.
    Liu MC; Proud D; Schleimer RP; Plaut M
    J Immunol; 1984 Jun; 132(6):2895-903. PubMed ID: 6609963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
    Shitara K; Ichimura O; Mitsuno T; Osawa T
    J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D; Stohl W; Mayer L
    J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of an encephalitogenic T lymphocyte line with a cellfree supernatant containing basic protein and I region gene products.
    Vandenbark AA; Teal P; Offner H
    J Immunol; 1987 Jan; 138(2):452-9. PubMed ID: 2432125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte mediation of lipopolysaccharide-stimulated macrophage metabolism.
    Ryan JL; Yohe WB
    J Immunol; 1981 Sep; 127(3):912-6. PubMed ID: 6973586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial purification of human lymphocyte activating factor.
    Lachman LB; Page SO; Metzgar RS
    Prep Biochem; 1980; 10(4):387-403. PubMed ID: 6774326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.
    Moore RN; Oppenheim JJ; Farrar JJ; Carter CS; Waheed A; Shadduck RK
    J Immunol; 1980 Sep; 125(3):1302-5. PubMed ID: 6774016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil product with lymphocyte activating factor activity.
    Harris PJ
    Clin Exp Immunol; 1982 Dec; 50(3):474-8. PubMed ID: 6984667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses.
    Farrar WL; Mizel SB; Farrar JJ
    J Immunol; 1980 Mar; 124(3):1371-7. PubMed ID: 6153680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymocyte differentiation activity from the cloned monocyte/macrophage cell line RAW 264.7. Alterations in the expression of immature thymocyte surface antigens.
    McKernan LN; Largen MT
    J Immunol; 1984 Sep; 133(3):1362-70. PubMed ID: 6379047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: biochemical relationship of high and low molecular weight forms of LAF.
    Togawa A; Oppenheim JJ; Mizel SB
    J Immunol; 1979 May; 122(5):2112-8. PubMed ID: 448118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.